Endovascular Abdominal Aortic Aneurysm Repair in a mild Haemophilia A Patient: a Case Report
Corresponding Author
P. Gautier
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Correspondence: Philippe Gautier, CHU de Caen, Département d'hématologie biologique, Avenue de la Côte de Nacre, 14033 Caen Cedex, France.
Tel.: +33 2 31 06 53 31; fax: 0033231065099;
e-mail: [email protected]
Search for more papers by this authorY. Repesse
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Search for more papers by this authorX. Troussard
Biological hematology department, CHU Caen, Caen, France
Search for more papers by this authorA. Borel-Derlon
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Search for more papers by this authorCorresponding Author
P. Gautier
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Correspondence: Philippe Gautier, CHU de Caen, Département d'hématologie biologique, Avenue de la Côte de Nacre, 14033 Caen Cedex, France.
Tel.: +33 2 31 06 53 31; fax: 0033231065099;
e-mail: [email protected]
Search for more papers by this authorY. Repesse
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Search for more papers by this authorX. Troussard
Biological hematology department, CHU Caen, Caen, France
Search for more papers by this authorA. Borel-Derlon
Biological hematology department, CHU Caen, Caen, France
Hemophilia Centre, CHU Caen, Caen, France
Search for more papers by this author
References
- 1Franchini M, Mannucci PM. Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012; 7: 24.
- 2Jacquemin M, Vantomme V, Buhot C et al. CD4+ T-Cell clones specific for wild-type factor VIII: a molecular machanism responsible for higher incidence of inhibitor formation in mild/moderate hemophilia A. Blood. 2003; 101: 1351–8.
- 3Maleux G, Koolen M, Heye S. Complications after endovascular aneurysm repair. Semin Intervent Radiol 2009; 26: 3–9.
- 4Marrocco-Trischitta MM, Melissano G, Castellano R et al. Endovascular abdominal aortic aneurysm repair in a patient with severe hemophilia B. J Endovasc Ther. 2009; 16: 120–3.
- 5Kobayashi M, Matsushita M, Nishikimi N et al. Treatment for abdominal aortic aneurysm in a patient with hemophilia A: a case report and review of the literature. J Vasc Surg 1997; 25: 945–8.
- 6Brown B, Steed DL, Webster MW et al. General surgery in adult hemophiliacs. Surgery 1986; 99: 154–9.
- 7Bergqvist D, Thimberg L, Bergentz SE et al. Abdominal aortic aneurysm surgery in a hemophiliac. Vasa 1985; 14: 394–7.
- 8Gula G, Frezza G. Successful surgery in a patient with haemophilia B: report of case with abdominal aneurysm. Vasc Surg. 1973; 7: 183–7.
- 9Maurel B, Bartoli MA, Jean-Baptiste E et al. Perioperative evaluation of iliac ZBIS branch devices: a French multicenter study. Ann Vasc Surg 2013; 2: 131–8.
- 10Darby SC, Keeling DM, Spooner RJ et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004; 2: 1047–54.
- 11Eckhardt CL, Menke LA, van Ommen CH et al. Intensive peri-operative use of factor VIII and the Arg593–>Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A. J Thromb Haemost 2009; 7(Suppl 6): 930–7.